AI, Patent Strategy, and What Actually Drives Outcomes in 2026. Part 2: AI and Patent Prosecution.
May 15, 2026
Part 1 focused on diligence and opinions. Patent prosecution is undergoing the same transition: AI has dramatically improved efficiency, but strategic value increasingly comes from understanding where...
See Full Guide
AI, Patent Strategy, and What Actually Drives Outcomes in 2026. Part 1: Due Diligence and Opinions.
Apr 21, 2026
This is the first article in a four-part series examining how AI is reshaping patent strategy across the lifecycle of life sciences assets—from diligence and prosecution to transactions and litigation...
See Full Guide
Strategies for Smaller/Early-Stage Life Science Companies. Part III: Choosing the Right Transaction
Sep 24, 2025
Understanding deal rationale is vital for small life science firms to choose and secure transactions. They must view deals from the acquirer’s perspective, showing commercial logic and IP value. Witho...
See Full Guide
Strategies for Smaller / Early-Stage Life Science Companies. Part II: Preparing for the Transaction
Sep 21, 2025
Strong IP is vital for life science startups aiming for tech transfer or acquisition. A smart IP strategy strengthens their position in negotiations with larger firms. Additional steps, outlined below...
See Full Guide
Strategies for Smaller and Early-Stage Life Science Companies: Part I: Creation of the Intellectual
Sep 20, 2025
For the life science industry, patents are more than just tools for blocking competitors. They are increasingly used to generate significant returns on R&D investments through licensing. Smaller and e...
See Full Guide
Ad
Transform legal challenges into solutions.
Connect now to review your situation.
The Avvo Rating explained
The Avvo Rating explained